News
02-13-2011, 09:20 PM
BioSante Pharmaceuticals, today announced positive safety data in its ongoing LibiGel Phase III clinical development program.
More... (http://www.news-medical.net/news/20110213/Positive-safety-data-from-BioSantes-ongoing-LibiGel-Phase-III-study-for-HSDD-treatment.aspx)
More... (http://www.news-medical.net/news/20110213/Positive-safety-data-from-BioSantes-ongoing-LibiGel-Phase-III-study-for-HSDD-treatment.aspx)